Koninklijke Philips N.V. (PHG)
USD 24.71
(-1.2%)
USD 24.71
(-1.2%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -115 Million EUR | 0.86% |
| 2022 | -116 Million EUR | -120.98% |
| 2021 | 553 Million EUR | -64.14% |
| 2020 | 1.54 Billion EUR | -6.2% |
| 2019 | 1.64 Billion EUR | -4.36% |
| 2018 | 1.71 Billion EUR | 13.32% |
| 2017 | 1.51 Billion EUR | -19.39% |
| 2016 | 1.88 Billion EUR | 89.72% |
| 2015 | 992 Million EUR | 104.12% |
| 2014 | 486 Million EUR | -75.59% |
| 2013 | 1.99 Billion EUR | 93.3% |
| 2012 | 1.03 Billion EUR | 482.9% |
| 2011 | -269 Million EUR | -113.03% |
| 2010 | 2.06 Billion EUR | 236.32% |
| 2009 | 614 Million EUR | 1037.04% |
| 2008 | 54 Million EUR | -97.09% |
| 2007 | 1.85 Billion EUR | 56.8% |
| 2006 | 1.18 Billion EUR | -33.45% |
| 2005 | 1.77 Billion EUR | 10.67% |
| 2004 | 1.6 Billion EUR | 229.4% |
| 2003 | 487.53 Million EUR | 16.01% |
| 2002 | 420.25 Million EUR | 130.6% |
| 2001 | -1.37 Billion EUR | -131.99% |
| 2000 | 4.29 Billion EUR | 144.47% |
| 1999 | 1.75 Billion EUR | 157.76% |
| 1998 | 681.27 Million EUR | -69.39% |
| 1997 | 2.22 Billion EUR | 166.33% |
| 1996 | 835.6 Million EUR | -51.21% |
| 1995 | 1.71 Billion EUR | 4.44% |
| 1994 | 1.63 Billion EUR | 50.61% |
| 1993 | 1.08 Billion EUR | 11.43% |
| 1992 | 977.17 Million EUR | -23.32% |
| 1991 | 1.27 Billion EUR | 39.82% |
| 1990 | 911.45 Million EUR | 21.72% |
| 1989 | 748.78 Million EUR | -16.9% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 337 Million EUR | -58.7% |
| 2024 Q2 | 816 Million EUR | 199.03% |
| 2024 Q1 | -824 Million EUR | -3533.33% |
| 2023 Q2 | 221 Million EUR | 137.91% |
| 2023 Q1 | -583 Million EUR | -354.59% |
| 2023 Q4 | 24 Million EUR | -89.29% |
| 2023 FY | -115 Million EUR | 0.86% |
| 2023 Q3 | 224 Million EUR | 1.36% |
| 2022 FY | -116 Million EUR | -120.98% |
| 2022 Q4 | 229 Million EUR | 114.98% |
| 2022 Q1 | -181 Million EUR | -211.73% |
| 2022 Q3 | -1.52 Billion EUR | -14000.0% |
| 2022 Q2 | 11 Million EUR | 106.08% |
| 2021 Q1 | -52 Million EUR | -106.54% |
| 2021 FY | 553 Million EUR | -64.14% |
| 2021 Q4 | 162 Million EUR | -54.75% |
| 2021 Q2 | 85 Million EUR | 263.46% |
| 2021 Q3 | 358 Million EUR | 321.18% |
| 2020 Q1 | 43 Million EUR | -94.11% |
| 2020 FY | 1.54 Billion EUR | -6.2% |
| 2020 Q2 | 229 Million EUR | 432.56% |
| 2020 Q3 | 476 Million EUR | 107.86% |
| 2020 Q4 | 795 Million EUR | 67.02% |
| 2019 Q3 | 320 Million EUR | -8.57% |
| 2019 Q2 | 350 Million EUR | 42.86% |
| 2019 Q1 | 245 Million EUR | -68.14% |
| 2019 FY | 1.64 Billion EUR | -4.36% |
| 2019 Q4 | 730 Million EUR | 128.13% |
| 2018 Q1 | 201 Million EUR | -72.2% |
| 2018 Q2 | 298 Million EUR | 48.26% |
| 2018 Q3 | 451 Million EUR | 51.34% |
| 2018 Q4 | 769 Million EUR | 70.51% |
| 2018 FY | 1.71 Billion EUR | 13.32% |
| 2017 Q4 | 723 Million EUR | 141.81% |
| 2017 FY | 1.51 Billion EUR | -19.39% |
| 2017 Q3 | 299 Million EUR | 18.65% |
| 2017 Q2 | 252 Million EUR | -27.59% |
| 2017 Q1 | 348 Million EUR | -57.87% |
| 2016 Q2 | 376 Million EUR | 88.94% |
| 2016 Q3 | 481 Million EUR | 27.93% |
| 2016 FY | 1.88 Billion EUR | 89.72% |
| 2016 Q1 | 199 Million EUR | 22.84% |
| 2016 Q4 | 826 Million EUR | 71.73% |
| 2015 Q1 | 139 Million EUR | -14.2% |
| 2015 Q2 | 349 Million EUR | 151.08% |
| 2015 Q3 | 342 Million EUR | -2.01% |
| 2015 Q4 | 162 Million EUR | -52.63% |
| 2015 FY | 992 Million EUR | 104.12% |
| 2014 Q2 | 332 Million EUR | 46.9% |
| 2014 Q3 | -91 Million EUR | -127.41% |
| 2014 Q4 | 162 Million EUR | 278.02% |
| 2014 FY | 486 Million EUR | -75.59% |
| 2014 Q1 | 226 Million EUR | -68.3% |
| 2013 Q1 | 305 Million EUR | 486.08% |
| 2013 Q2 | 509 Million EUR | 66.89% |
| 2013 Q3 | 464 Million EUR | -8.84% |
| 2013 Q4 | 713 Million EUR | 53.66% |
| 2013 FY | 1.99 Billion EUR | 93.3% |
| 2012 Q4 | -79 Million EUR | -123.72% |
| 2012 FY | 1.03 Billion EUR | 482.9% |
| 2012 Q3 | 333 Million EUR | -1.48% |
| 2012 Q2 | 338 Million EUR | -22.83% |
| 2012 Q1 | 438 Million EUR | 67.18% |
| 2011 Q4 | 262 Million EUR | -4.03% |
| 2011 FY | -269 Million EUR | -113.03% |
| 2011 Q3 | 273 Million EUR | 124.31% |
| 2011 Q1 | 318 Million EUR | -57.88% |
| 2011 Q2 | -1.12 Billion EUR | -453.14% |
| 2010 Q2 | 404 Million EUR | 3.86% |
| 2010 Q4 | 755 Million EUR | 46.03% |
| 2010 Q3 | 517 Million EUR | 27.97% |
| 2010 FY | 2.06 Billion EUR | 236.32% |
| 2010 Q1 | 389 Million EUR | -29.91% |
| 2009 Q1 | -186 Million EUR | 15.15% |
| 2009 FY | 614 Million EUR | 1037.04% |
| 2009 Q4 | 555 Million EUR | 134.18% |
| 2009 Q3 | 237 Million EUR | 2862.5% |
| 2009 Q2 | 8 Million EUR | 104.3% |
| 2008 Q1 | 174.76 Million EUR | -80.04% |
| 2008 Q2 | 325.35 Million EUR | 86.17% |
| 2008 FY | 54 Million EUR | -97.09% |
| 2008 Q3 | 36.88 Million EUR | -88.66% |
| 2008 Q4 | -219.2 Million EUR | -694.35% |
| 2007 FY | 1.85 Billion EUR | 56.8% |
| 2007 Q1 | 291.93 Million EUR | -56.1% |
| 2007 Q4 | 875.61 Million EUR | 127.18% |
| 2007 Q3 | 385.42 Million EUR | 27.56% |
| 2007 Q2 | 302.15 Million EUR | 3.5% |
| 2006 Q4 | 665.06 Million EUR | 2537.6% |
| 2006 Q2 | 367.03 Million EUR | 9.58% |
| 2006 FY | 1.18 Billion EUR | -33.45% |
| 2006 Q1 | 334.95 Million EUR | -66.37% |
| 2006 Q3 | 25.21 Million EUR | -93.13% |
| 2005 Q2 | 147.01 Million EUR | -23.77% |
| 2005 FY | 1.77 Billion EUR | 10.67% |
| 2005 Q4 | 995.95 Million EUR | 125.65% |
| 2005 Q3 | 441.36 Million EUR | 200.21% |
| 2005 Q1 | 192.85 Million EUR | 1400.98% |
| 2004 Q3 | 1.01 Billion EUR | 186.36% |
| 2004 Q4 | 12.84 Million EUR | -98.74% |
| 2004 Q2 | 355.81 Million EUR | 63.57% |
| 2004 FY | 1.6 Billion EUR | 229.4% |
| 2004 Q1 | 217.52 Million EUR | -64.2% |
| 2003 Q2 | -26.07 Million EUR | -181.39% |
| 2003 Q1 | 32.03 Million EUR | -32.7% |
| 2003 Q4 | 607.63 Million EUR | 581.85% |
| 2003 FY | 487.53 Million EUR | 16.01% |
| 2003 Q3 | -126.1 Million EUR | -383.65% |
| 2002 FY | 420.25 Million EUR | 130.6% |
| 2002 Q4 | 47.6 Million EUR | -45.97% |
| 2002 Q2 | 37.24 Million EUR | -49.28% |
| 2002 Q3 | 88.1 Million EUR | 136.55% |
| 2002 Q1 | 73.42 Million EUR | 120.26% |
| 2001 Q4 | -362.43 Million EUR | 35.39% |
| 2001 FY | -1.37 Billion EUR | -131.99% |
| 2001 Q3 | -560.92 Million EUR | 24.69% |
| 2001 Q1 | 332.19 Million EUR | -83.05% |
| 2001 Q2 | -744.78 Million EUR | -324.2% |
| 2000 Q4 | 1.95 Billion EUR | 107.3% |
| 2000 Q1 | 663.35 Million EUR | -52.76% |
| 2000 Q2 | 725.41 Million EUR | 9.36% |
| 2000 Q3 | 945.47 Million EUR | 30.33% |
| 2000 FY | 4.29 Billion EUR | 144.47% |
| 1999 Q1 | 549 Million EUR | 247.0% |
| 1999 FY | 1.75 Billion EUR | 157.76% |
| 1999 Q3 | 351.66 Million EUR | 10.33% |
| 1999 Q4 | 1.4 Billion EUR | 299.35% |
| 1999 Q2 | 318.74 Million EUR | -41.94% |
| 1998 Q4 | -373.45 Million EUR | -263.01% |
| 1998 Q3 | 229.1 Million EUR | -47.7% |
| 1998 Q1 | 383.47 Million EUR | -51.55% |
| 1998 FY | 681.27 Million EUR | -69.39% |
| 1998 Q2 | 438.07 Million EUR | 14.24% |
| 1997 Q2 | 521.97 Million EUR | 36.06% |
| 1997 Q3 | 532.1 Million EUR | 1.94% |
| 1997 Q4 | 791.46 Million EUR | 48.74% |
| 1997 FY | 2.22 Billion EUR | 166.33% |
| 1997 Q1 | 383.62 Million EUR | 101.81% |
| 1996 FY | 835.6 Million EUR | -51.21% |
| 1996 Q4 | -21.17 Billion EUR | -383.23% |
| 1996 Q2 | 7.63 Billion EUR | 0.82% |
| 1996 Q1 | 7.57 Billion EUR | 138.56% |
| 1996 Q3 | 7.47 Billion EUR | -2.14% |
| 1995 Q4 | -19.65 Billion EUR | -367.82% |
| 1995 Q3 | 7.33 Billion EUR | 4.07% |
| 1995 Q2 | 7.05 Billion EUR | 5.97% |
| 1995 FY | 1.71 Billion EUR | 4.44% |
| 1995 Q1 | 6.65 Billion EUR | 133.8% |
| 1994 Q1 | 7.59 Billion EUR | 141.66% |
| 1994 FY | 1.63 Billion EUR | 50.61% |
| 1994 Q3 | 7.1 Billion EUR | -3.08% |
| 1994 Q2 | 7.33 Billion EUR | -3.48% |
| 1994 Q4 | -19.68 Billion EUR | -376.93% |
| 1993 Q1 | 6.3 Billion EUR | 139.1% |
| 1993 Q3 | 6.44 Billion EUR | -1.44% |
| 1993 FY | 1.08 Billion EUR | 11.43% |
| 1993 Q4 | -18.23 Billion EUR | -383.1% |
| 1993 Q2 | 6.53 Billion EUR | 3.64% |
| 1992 Q3 | 6.03 Billion EUR | -3.4% |
| 1992 Q2 | 6.24 Billion EUR | 10.99% |
| 1992 FY | 977.17 Million EUR | -23.32% |
| 1992 Q4 | -16.13 Billion EUR | -367.33% |
| 1992 Q1 | 5.62 Billion EUR | 132.27% |
| 1991 Q3 | 8.37 Billion EUR | 43.37% |
| 1991 Q1 | 1.59 Billion EUR | 109.4% |
| 1991 Q4 | -17.44 Billion EUR | -308.23% |
| 1991 Q2 | 5.84 Billion EUR | 265.85% |
| 1991 FY | 1.27 Billion EUR | 39.82% |
| 1990 Q3 | 7.19 Billion EUR | 22.89% |
| 1990 FY | 911.45 Million EUR | 21.72% |
| 1990 Q1 | 5.67 Billion EUR | 134.83% |
| 1990 Q2 | 5.85 Billion EUR | 3.15% |
| 1990 Q4 | -16.98 Billion EUR | -335.87% |
| 1989 FY | 748.78 Million EUR | -16.9% |
| 1989 Q4 | -16.3 Billion EUR | -380.17% |
| 1989 Q1 | 5.22 Billion EUR | 128.92% |
| 1989 Q2 | 5.81 Billion EUR | 11.32% |
| 1989 Q3 | 5.82 Billion EUR | 0.04% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Abbott Laboratories | 6.47 Billion USD | 101.775% |
| Allurion Technologies Inc. | -78.07 Million USD | -47.289% |
| Artivion, Inc. | 5.74 Million USD | 2102.786% |
| Avanos Medical, Inc. | 4.2 Million USD | 2838.095% |
| Butterfly Network, Inc. | -145.61 Million USD | 21.022% |
| Butterfly Network, Inc. | -145.61 Million USD | 21.022% |
| Bio-Rad Laboratories, Inc. | 383.79 Million USD | 129.964% |
| Boston Scientific Corporation | 2.34 Billion USD | 104.908% |
| Perspective Therapeutics, Inc. | -15.18 Million USD | -657.476% |
| CONMED Corporation | 130.78 Million USD | 187.93% |
| Edwards Lifesciences Corporation | 1.53 Billion USD | 107.496% |
| Paragon 28, Inc. | -37.3 Million USD | -208.237% |
| Glaukos Corporation | -128.7 Million USD | 10.645% |
| Globus Medical, Inc. | 133.14 Million USD | 186.374% |
| Inspire Medical Systems, Inc. | -40.27 Million USD | -185.565% |
| Integer Holdings Corporation | 167.33 Million USD | 168.726% |
| Medtronic plc | 5.14 Billion USD | 102.236% |
| Nevro Corp. | -99.3 Million USD | -15.801% |
| Owlet, Inc. | -28.63 Million USD | -301.649% |
| Penumbra, Inc. | 73.55 Million USD | 256.354% |
| Vicarious Surgical Inc. | -80.66 Million USD | -42.563% |
| Smith & Nephew plc | 425 Million USD | 127.059% |
| Sonendo, Inc. | -57.74 Million USD | -99.158% |
| STERIS plc | 836.11 Million USD | 113.754% |
| Stryker Corporation | 3.88 Billion USD | 102.958% |
| Vapotherm, Inc. | -39.08 Million USD | -194.268% |
| Zimmer Biomet Holdings, Inc. | 1.27 Billion USD | 109.001% |